125 related articles for article (PubMed ID: 31804317)
1. Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013.
Tramontano AC; Chen Y; Watson TR; Eckel A; Sheehan DF; Peters MLB; Pandharipande PV; Hur C; Kong CY
Medicine (Baltimore); 2019 Dec; 98(49):e18082. PubMed ID: 31804317
[TBL] [Abstract][Full Text] [Related]
2. Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013.
Tramontano AC; Chen Y; Watson TR; Eckel A; Hur C; Kong CY
Cancer Med; 2019 Sep; 8(11):5158-5172. PubMed ID: 31347306
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
Cipriano LE; Romanus D; Earle CC; Neville BA; Halpern EF; Gazelle GS; McMahon PM
Value Health; 2011 Jan; 14(1):41-52. PubMed ID: 21211485
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic disparities in colorectal cancer treatment utilization and phase-specific costs, 2000-2014.
Tramontano AC; Chen Y; Watson TR; Eckel A; Hur C; Kong CY
PLoS One; 2020; 15(4):e0231599. PubMed ID: 32287320
[TBL] [Abstract][Full Text] [Related]
7. Projections of the cost of cancer care in the United States: 2010-2020.
Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
[TBL] [Abstract][Full Text] [Related]
8. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
9. Costs of Cancer Care Across the Disease Continuum.
Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
[TBL] [Abstract][Full Text] [Related]
10. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
11. Costs and trends in pancreatic cancer treatment.
O'Neill CB; Atoria CL; O'Reilly EM; LaFemina J; Henman MC; Elkin EB
Cancer; 2012 Oct; 118(20):5132-9. PubMed ID: 22415469
[TBL] [Abstract][Full Text] [Related]
12. Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US.
Bhattacharya K; Bentley JP; Ramachandran S; Chang Y; Banahan BF; Shah R; Bhakta N; Yang Y
JAMA Netw Open; 2021 Jul; 4(7):e2116357. PubMed ID: 34241627
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
14. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
15. Estimating health care costs related to cancer treatment from SEER-Medicare data.
Brown ML; Riley GF; Schussler N; Etzioni R
Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
[TBL] [Abstract][Full Text] [Related]
16. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
[TBL] [Abstract][Full Text] [Related]
17. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
18. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
Etzioni R; Ramsey SD; Berry K; Brown M
Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
[TBL] [Abstract][Full Text] [Related]
19. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
[TBL] [Abstract][Full Text] [Related]
20. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
